Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
novel transcript, antisense to leucine-rich repeat containing 10B
- Molecular classification
- Other, non-coding RNA, antisense RNA
01
Overview
Novel transcript, antisense to leucine-rich repeat containing 10B, refers to a non-protein-coding RNA that is transcribed in the opposite direction to the LRRC10B gene. While antisense RNAs can sometimes regulate the expression of their sense gene partners, there is no current evidence that this particular transcript is a recognized therapeutic target, nor is there established information about its function, role in disease, or interactions with drugs. The designation "novel transcript" generally indicates it has been computationally annotated or observed in RNA sequencing data, but not necessarily characterized functionally or therapeutically.
- Other names
- antisense to LRRC10BENSG00000301919
Beyond the preview
Go deeper on novel transcript, antisense to leucine-rich repeat containing 10B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel transcript, antisense to leucine-rich repeat containing 10B.